Abstract
Choriocarcinoma is an early metastasizing and highly invasive tumor and characterized as a high-level human chorionic gonadotropin-secreting tumor. It normally arises in the gestational trophoblast, gonads and much less frequently in the stomach. Primary gastric choriocarcinoma appears to have a poor prognosis; especially with liver metastasis, the survival period is expected to be <1 month. This unfavorable clinical outcome is partly due to the lack of defined chemotherapy against primary gastric choriocarcinoma. We herein report a case of a 68-year-old male primary gastric choriocarcinoma patient with advanced liver metastases in which germ cell tumor-based chemotherapy achieved a pathological complete response and 2-year disease-free survival.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / metabolism
-
Choriocarcinoma, Non-gestational / drug therapy*
-
Choriocarcinoma, Non-gestational / pathology
-
Choriocarcinoma, Non-gestational / secondary*
-
Chorionic Gonadotropin, beta Subunit, Human / metabolism
-
Cisplatin / administration & dosage
-
Disease-Free Survival
-
Docetaxel
-
Etoposide / administration & dosage
-
Fluorouracil / administration & dosage
-
Humans
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / pathology
-
Liver Neoplasms / secondary*
-
Liver Neoplasms / surgery
-
Male
-
Neoplasm, Residual / surgery
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Survival Analysis
-
Taxoids / administration & dosage
Substances
-
Biomarkers, Tumor
-
Chorionic Gonadotropin, beta Subunit, Human
-
Taxoids
-
Docetaxel
-
Etoposide
-
Cisplatin
-
Fluorouracil